Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000357083

Medchemexpress LLC JPS014 TFA | 98.12% | C48H60F3N7O9S | 25 MG
SDP

Catalog No. 5000357083
Encompass_Preferred

JPS014 TFA is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC). It degrades class I histone deacetylase (HDAC) and is a potent HDAC1/2 degrader. This degradation correlates with a greater number of total differentially expressed genes and enhanced apoptosis in HCT116 cells.

  • Benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC)
  • Degrades class I histone deacetylase (HDAC)
  • Potent HDAC1/2 degrader
  • Correlates with greater total differentially expressed genes
  • Enhances apoptosis in HCT116 cells

Catalog No. 50-003-57083 Supplier Medchemexpress LLC Supplier No. 25MGHY145815A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

JPS014 TFA is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC). It degrades class I histone deacetylase (HDAC) and is a potent HDAC1/2 degrader. This degradation correlates with a greater number of total differentially expressed genes and enhanced apoptosis in HCT116 cells.

  • Benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimera (PROTAC)
  • Degrades class I histone deacetylase (HDAC)
  • Potent HDAC1/2 degrader
  • Correlates with greater total differentially expressed genes
  • Enhances apoptosis in HCT116 cells

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.